February 18, 2015 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) sold Celldex Therapeutics, Inc., a stock transaction, valued at $15,001 - $50,000. The trade took place on February 18, 2015 and was disclosed on March 4, 2015 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.